Pharmaceuticals division of the German group Bayer, with its main research and business site in Berlin alongside the group head office at Leverkusen. Discovers, develops, makes and sells prescription medicines in cardiology and haematology, oncology, women's health, ophthalmology and radiology, including Xarelto, Eylea and Nubeqa, and runs its own discovery research, non-clinical safety and toxicology, clinical development and manufacturing across Europe, the Americas and Asia.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét